Research Article
1 March 2001

Molecular Characterization of a NovelStaphylococcus aureus Serine Protease Operon

ABSTRACT

The present study identified and characterized a unique operon (spl) encoding six serine protease-like proteins. In addition, native Spl proteins were isolated and characterized. Typical of most exoproteins, the spl gene products contain putative 35- or 36-amino-acid signal peptides. The Spl proteins share 44 to 95% amino acid sequence identity with each other and 33 to 36% sequence identity with V8 protease. They also contain amino acids found in catalytic triads of enzymes in the trypsin-like serine protease family, and SplB and SplC were shown to degrade casein. The sploperon is transcribed on a 5.5-kb transcript, but several nonrandom degradation products of this transcript were also identified. Similar to other S. aureus exoprotein genes, the sploperon is maximally expressed during the transition into stationary phase and is positively controlled by the Agr virulence factor regulator. The Sar regulatory system did not affect sploperon expression. PCR analysis revealed the presence of thespl operon in 64% of the S. aureus isolates tested, although one spl operon-negative isolate was shown to contain at least two of the spl genes. Finally, intraperitoneal injection of an spl operon deletion mutant revealed no major differences in virulence compared to the parental strain.
Staphylococcus aureusexports a wide variety of exoenzymes, some of which are known virulence factors. Among these enzymes are a variety of proteases, such as metalloprotease, thiolprotease, and the serine proteases V8 and exfoliative toxin A (ETA) and ETB. The best characterized of these, V8 serine protease, was initially isolated from S. aureusstrain V8 but has since been shown to be expressed by 67% of theS. aureus isolates tested (2, 11).
Like most exoproteins produced by S. aureus, the Agr regulatory system positively regulates extracellular protease expression in response to increasing cell density (7, 26). In contrast, the Sar regulatory system has a negative effect on protease expression. Recent studies indicate that pleiotropic alterations in exoprotein profiles caused by sar mutations are due to the derepression of staphylococcal proteases, which then leads to exoprotein degradation (7, 9). In addition, McGavin et al. (21) reported that V8 protease modifies the fibronectin-binding phenotype of S. aureus. Thus, secreted proteases could play an important role in the posttranslational regulation of S. aureus exoprotein activity, in addition to modifying host proteins to the benefit of the bacteria.
In this study, we identified a novel S. aureus operon (designated spl) that encodes six previously uncharacterized serine protease-like proteins. This operon is expressed during the transition to stationary phase and is positively regulated by Agr. In addition, two of the Spl proteins expressed by this operon were shown to exhibit proteolytic activity.

MATERIALS AND METHODS

Bacterial strains and plasmids.

The bacterial strains and plasmids used in this study are listed in Table1. S. aureus strains were routinely grown in tryptic soy broth (TSB; Difco Laboratories, Detroit, Mich.) containing erythromycin (5 μg/ml), kanamycin (50 μg/ml), or tetracycline (5 μg/ml) where indicated. Escherichia colistrains were grown in Luria-Bertani medium (Fisher Biotech) with ampicillin selection (50 μg/ml). All bacterial cultures were routinely incubated at 37°C and aerated by shaking at 250 rpm.
Table 1.
Table 1. Strains and plasmids used in this study
Strain or plasmidRelevant phenotypeReference or source
S. aureus  
 RN6390Wild-type laboratory strain23
 RN4220Highly transformable strain23
 RN6911agr RN6390 strain18
 ALC135agr sar RN6390 strain8
 ALC136sar RN6390 strainAmbrose Cheung
 KB600RN6390 spl operon null mutantThis study
 KB601RN6390 splB mutantThis study
 BrittinghamTSSa isolateAmy Bryant
 Israel #1TSS isolateAmy Bryant
 Israel #2TSS isolateAmy Bryant
 NewmanProduces type 5 capsuleChia Y. Lee
 MProduces type 1 capsuleChia Y. Lee
 WrightProduces type 8 capsuleChia Y. Lee
 BeckerProduces type 8 capsuleChia Y. Lee
 ColMRSAbJohn J. Iandolo
 DU4916MRSAJohn J. Iandolo
 NovelBovine mastitis isolate33
 305Bovine mastitis isolate22
E. coli DH5αHighly transformable strainBethesda Research Laboratories
Plasmids  
 pCL52.2Temperature-sensitive cloning vector30
 pER924Temperature-sensitive cloning vector5
 pRN5548High-copy gram-positive plasmid24
 pDG647Source of Emr cassette16
 pSR7pRN5548 derivative used in expression ofsplABCDThis study
a
TSS, toxic shock syndrome.
b
MRSA, methicillin-resistant S. aureus.

DNA manipulations.

E. coli plasmid DNA was extracted using the Wizard Plus DNA Purification System (Promega, Madison, Wis.). Restriction endonucleases and T4 DNA ligase were purchased from GIBCO-BRL (Gaithersburg, Md.) and used as recommended by the manufacturer. Transformations of E. coli strain DH5α and S. aureus RN4220 were performed using the procedures described by Inoue et al. (17) and Kraemer and Iandolo (19), respectively. S. aureus chromosomal DNA was isolated using the method of Dyer and Iandolo (13), and plasmid DNA was isolated using the Wizard Plus DNA Purification System, except that S. aureus cells were converted to protoplasts using lysostaphin (50 μg/ml). Bacteriophage transductions in S. aureus were performed as described by Shafer and Iandolo (32) using φ11 as the transducing phage.

Identification of the spl operon by database analysis.

Several proteins with similar physiochemical properties were purified from S. aureus cultures. N-terminal sequence data was used in a BLAST search to screen the S. aureus 8325 (the parent strain of RN6390) sequencing database provided by theStaphylococcus aureus Genome Sequencing Project (University of Oklahoma Health Sciences Center). The N-terminal sequences used originally matched open reading frames found on two separate contigs. One contig contained the splA, splB, and splCgenes, while the other contig contained part of splD and all of splE and splF. Since a search of the S. aureus COL genome database (The Institute for Genome Research) indicated that these six genes make up a single operon, the sequence between the two 8325 contigs was PCR amplified and sequenced. The nucleotide sequence of the entire spl operon from 8325 was entered into the GenBank database (accession no. AF271715 ). The nucleotide sequences of the splB and splC genes were previously identified and included in the GenBank database asorf1 and orf2 (accession numbers U60589 andU63529, respectively).

Purification and N-terminal sequencing.

S. aureusstrain RN6390 was grown with shaking at 37°C in 5 liters of Todd-Hewitt broth (Difco Laboratories) to late stationary phase. The culture was precipitated in 4 volumes of ethanol for 1 week at 4°C. The precipitate was collected by centrifugation ( 13,000 × g for 15 min at 4°C) and air dried. Proteins in the pellet were dissolved in 50 ml of water and clarified by centrifugation at 40,000 × g at 4°C for 30 min. After dialysis against multiple changes of water (4°C), the volume of the dialysate was reduced to less than 100 ml by pervaporation. The dialysate was then subjected to flatbed isoelectric focusing (IEF) in a gradient of ampholytes (pH 3 to 10) in Sephadex (Amersham Pharmacia Biotech, Piscataway, N.J.). The IEF gel was divided into 19 fractions. Proteins were eluted from each fraction and then dialyzed exhaustively at 4°C against multiple changes of water. Proteins in each fraction were resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and visualized by staining with Coomassie blue. The SplA, SplB, and SplF triplet was further purified using a fast protein liquid chromatography (FPLC) sizing column (Superose 12 HR 10/30; Amersham Pharmacia Biotech). The purified Spl proteins were then separated on an SDS-PAGE gel containing 2.0 M urea and transferred to a polyvinylidene difluoride membrane (Millipore Corporation, Bedford, Mass.) according to the method of Matsudaira (20). SplB and SplC (from a separate IEF fraction) were further purified by reverse-phase high-pressure liquid chromatography (HPLC) using a Hewlett-Packard HP1090 (Hewlett-Packard, Waldbronn, Germany) apparatus equipped with a 15-cm C18 column (VYDAC, Hesperia, Calif.). Protein was loaded onto the column in 0.1% trifluoroacetic acid and eluted in a gradient of 0 to 60% acetonitrile in 0.1% trifluoroacetic acid with a flow rate of 1 ml/min. The N-terminal amino acid sequences of the purified Spl proteins were determined by Edman degradation (Laboratory for Bioanalysis and Biotechnology, Pullman, Wash.).

Zymographic analysis.

S. aureus cultures were grown in 10 ml of TSB to late stationary phase. Cultures then were centrifuged at 6,000 × g for 5 min (4°C), and the supernatant was filter sterilized through a 0.2-μm-pore-size filter (Pall Corporation, Ann Arbor, Mich.). The exoproteins were concentrated by passage through a Centricon 3 centrifugal filter device (Millipore) at 4°C by following the manufacturer's instructions. Protease activity associated with Spl proteins was detected using zymographic analysis essentially as described by Arvidson et al. (2). A 52.5-μl volume of each sample was mixed with 17.5 μl of 4× sample buffer (without β-mercaptoethanol) and denatured for 15 min at room temperature. The samples were loaded on an SDS–12% polyacrylamide gel containing 0.1% β-casein (Sigma, St. Louis, Mo.), and electrophoresis was performed with a constant voltage of 120 V using buffer precooled to 4°C. Renaturation of proteases was obtained by incubating the gels in 2.5% (vol/vol) Triton X-100 for 30 min with gentle agitation at room temperature. Gels were then placed in development buffer (50 mM Tris, 200 mM NaCl, 5 mM CaCl2, 0.02% Brij 35) for 10 to 12 h with gentle agitation at 37°C and stained with 0.5% Coomassie blue. Zones of hydrolysis were visualized after destaining in a 40% methanol–10% acetic acid solution.

spl operon mutagenesis.

The S. aureus spl operon was deleted in strain RN6390 by allele replacement as follows. Initially, a 480-bp DNA fragment spanning a region 3′ tosplF was PCR amplified using Taq DNA polymerase (GIBCO-BRL) and the splD3 and splD4 primers (5′-GGTAATAAGCCATCAGGTGAAAGCTCTAGAGG-3′ and 5′-GCGAACGTTGTTCTGCAGTAATAGAC-3′, respectively; see Fig. 2). The DNA product was then digested with XbaI andPstI (underlined sequences) and ligated into theXbaI and PstI sites of pDG647 downstream of the plasmid-encoded erythromycin resistance (Emr) cassette. This recombinant plasmid was designated pSR1.
Similarly, a 450-bp DNA fragment spanning a region 5′ tosplA was PCR amplified using the primers splA1 and splA2 (5′-GTTTCATTGATGAATTCATATTGGC-3′ and 5′-GTTAAAATAGTTAAAGCAGTGGTACCTTTAACC-3′, respectively; see Fig. 2). This fragment was then digested withEcoRI and KpnI (underlined sequences) and ligated into the EcoRI and KpnI restriction sites of the plasmid pSR1 upstream of the (Emr) cassette. This recombinant plasmid, designated pSR2, was then digested withPstI and EcoRI, and the resulting fragment containing the Emr cassette and the two flankingspl sequences was ligated into pCL52.2, generating pSR3. This plasmid was transformed into S. aureus RN4220 and subsequently transferred into RN6390 by bacteriophage-mediated transduction. This strain was grown at the nonpermissive temperature (43°C) on Trypticase soy agar (TSA) plates containing tetracycline to select for cells in which the plasmid had been integrated into the RN6390 chromosome by homologous recombination. To allow a second recombination event to occur, a single colony was inoculated into antibiotic-free TSB and grown at 30°C for 5 days with 1:1,000 dilution into fresh medium each day. After day 5, the bacteria were transferred to TSA containing erythromycin and isolated colonies were screened for the loss of tetracycline resistance. PCR amplification and Southern blot analysis (data not shown) confirmed the replacement of the spl operon. This spl mutant strain was designated KB600.
A specific disruption of splB was achieved by PCR amplifying a 320-bp DNA fragment internal to splB using the primers splB1 and splB2 (5′-GATACTAATATTTTTCCATATACTGG-3′ and 5′-CGCTCACAAGCTTTAGCCCCTGCCGC-3′, respectively). This amplified fragment was ligated into the EcoRV site of pBluescript II KS (Stratagene, La Jolla, Calif.) and subsequently ligated into the EcoRI/KpnI sites of pER924 (Table 1). This recombinant plasmid was then electroporated intoS. aureus strain RN4220, which was spread onto TSA containing erythromycin, and incubated at 30°C overnight. The plasmid was then transferred into RN6390 by phage-mediated transduction. This strain was grown at the nonpermissive temperature (43°C) in the presence of erythromycin to select for cells in which the plasmid had been integrated into the RN6390 chromosome via homologous recombination. PCR amplification and Southern blot analysis confirmed that splB had been disrupted (data not shown). This strain was designated KB601.

spl operon expression construct.

For use in complementation experiments, the spl operon (excluding the promoter region) was PCR amplified using primers splA3 (5′-CATTAACTATAAAAATAAGCTTGGAAGGAGG-3′) and splD2 (5′-GTATATTTTGTCAGGATCCGGTGAATGTCTAAG-3′) and then cloned into the BamHI andHindIII sites (underlined sequences) of pBluescript II KS. This 5.0-kb DNA fragment was then liberated by digestion withBamHI and SalI, ligated to the corresponding sites within pRN5548, and transformed into S. aureus RN4220. Plasmid DNA from one positive clone was then transferred to variousS. aureus strains by electroporation. This plasmid construct, designated pSR7, placed the expression of the sploperon under the control of the constitutively expressed β-lactamase promoter.

Northern blot analysis.

To examine growth phase-dependent expression, cultures were diluted 1:100 in TSB and grown with aeration at 37°C. At 4, 6, 8, 10, and 12 h after inoculation, 10-ml culture aliquots were mixed with an equal volume of ethanol-acetone solution (1:1, vol/vol) and the cells were stored at −20°C. After sampling was complete, the cell suspensions were centrifuged at 6,000 × g (4°C) for 5 min and the pellets were resuspended in 10 ml of TEN buffer (29). The cells were centrifuged again, and the pellets were resuspended in 1 ml of TEN buffer (containing 2.5 M NaCl). The cells were converted to protoplasts by incubation (37°C, 25 min) in the presence of recombinant lysostaphin (50 μg/ml). RNA was isolated using 4 ml of Trizol (GIBCO-BRL) in accordance with the manufacturer's instructions and resuspended in sterile, dimethylpyrocarbonate-treated water containing 0.5% SDS.
Twenty micrograms of RNA (determined by spectrophotometric analysis) from each S. aureus strain was incubated at 55°C in denaturing buffer (5% 10× morpholinepropanesulfonic acid [MOPS], 5.5% formaldehyde [37%, wt/vol], 50% formamide) for 15 min and resolved by electrophoresis through a 0.8% agarose gel containing formaldehyde (3). The RNA was transferred to a charged nylon membrane (MSI, Westboro, Mass.) using downward capillary action (29). For dot blot analysis, 20- and 40-μg portions of RNA were denatured as described above and applied to a charged nylon membrane using a dot blot manifold. Immobilized RNA was cross-linked twice on each side of the membrane using a UV Stratalinker 1800 (Stratagene). Next, prehybridization was carried out at 65°C for 1 h in 50 ml of hybridization buffer (5× SSC [1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate]; 0.02% SDS, 0.1%N-laurylsarcosine, 1% blocking stock [10% blocking reagent from Boehringer Mannheim, Indianapolis, Ind.] in maleic acid buffer). Digoxigenin (DIG)-labeled gene-specific DNA probes were generated using a PCR DIG Probe Synthesis Kit (Boehringer Mannheim) with primers specific for each spl gene. Hybridization withspl-specific probes (see above) was carried out at 65°C in hybridization buffer containing heat-denatured DIG-dUTP-labeled probe for 12 to 16 h. Membranes were washed twice (for 15 min each time) in 20× SSC–0.01% SDS and then twice (for 30 min each time) in 0.5× SSC–0.01% SDS. All washes were carried out at room temperature (with the exception of the second wash in 0.5× SSC–0.1% SDS, which was performed in a water bath at 68°C) with gentle agitation. The remainder of the detection procedure followed the protocol in theDIG System User's Guide for Filter Hybridization.

Virulence studies.

In an initial study to examine if thespl operon contributes to virulence, 29-day-old male Sprague-Dawley rats were given intraperitoneal injections of S. aureus RN6390, KB600, and KB600(pSR7). The dosages used were 107, 108, and 109 CFU in a 500-μl volume. The overall health and viability of the rats were assessed over a 3-day period. After this time, the rats were sacrificed and their organs were examined by visual inspection and bacterial culturing.

RESULTS

Purification and physiochemical characterization of novel exoproteins.

Fractionation of proteins in S. aureusRN6390 culture supernatants revealed a comigrating group of three extremely basic and similarly sized proteins (SplA, SplB, and SplF) ranging from 26 to 28 kDa (Fig. 1A). Upon preparative IEF, these proteins migrated to the same position in the pH gradients representing pIs of approximately 9.0. Further purification using FPLC resulted in an apparently pure protein preparation containing only these three Spl proteins (Fig. 1A, lane 4). To identify the proteins, they were separated by SDS-PAGE, transferred to polyvinylidene difluoride membrane, and subjected to N-terminal sequencing. The results of this analysis revealed that the N-terminal sequences of the proteins from the upper, middle, and lower bands were ENNVTKVKDTNIFPYTGVVAF, EKNVKEITDATKEPY, and ENTVKQITNTNVAPYSG, respectively.
Fig. 1.
Fig. 1. Purification of the Spl proteins. (A) The Spl proteins from S. aureus RN6390 grown to stationary phase were fractionated and then separated by SDS–12% PAGE. Lanes: 1, 10-kDa molecular size markers (Gibco-BRL); 2, exoproteins from an RN6390 culture; 3, partially purified exoproteins after IEF fractionation; 4, FPLC fraction containing purified SplA, SplB, and SplF separated in the presence of 2.0 M urea to enhance the resolution of these proteins; 5, purified SplC; 6, purified SplB. The molecular size standards used were the BenchMark Protein Ladder (Gibco-BRL). (B) Zymographic analysis of purified SplC (lane 2) and SplB (lane 3) using casein as the substrate. The molecular size markers used (lane 1) were the BenchMark Prestained Protein Ladder (Gibco-BRL).

Identification of spl genes in the S. aureus database.

Comparison of the N-terminal sequences of the purified proteins to the S. aureus 8325 genome database indicated that these proteins were encoded by genes within a six-gene operon (Fig. 2). The N-terminal sequences of the proteins from the upper, middle, and lower bands (Fig. 1A, lane 4) were identical to the deduced amino acid sequences of the first, second, and sixth gene products, respectively. Interestingly, products of all six genes share 43.9 to 94.6% sequence identity with each other and, as a group, contain significant sequence similarity to known serine proteases (Fig. 3 and4) such as S. aureus V8 protease and the epidermolytic toxins. Notably, each gene product contains the conserved amino acids His-74, Asp-113, and Ser-189 (splA gene product numbering), which make up the classic catalytic triad of trypsin-like serine proteases (Fig. 3). Unlike V8 protease, the Spl proteins appear to be synthesized without propeptides. Because of their sequence similarities to serine proteases, the genes encoding these proteins were designatedsplA, splB, splC, splD, splE, and splF for serine protease like.
Fig. 2.
Fig. 2. Schematic representation of the S. aureus sploperon (middle) and its disruption by plasmid insertion (top) and allele replacement (bottom). The PCR primers (splA1, splA2, splD3, and splD4) used to generate DNA fragments for allele replacement are indicated. The arrows 5′ and 3′ to the spl operon represent the putative position of the transcription start site and a putative factor-independent transcription terminator, respectively.
Fig. 3.
Fig. 3. Sequence alignment of SplA to F with staphylococcal V8 serine protease. High sequence conservation throughout the proteins is evident. Identical residues in all five sequences are boxed. The asterisks indicate residues comprising the catalytic triad.
Fig. 4.
Fig. 4. Sequence identities among the Spl proteins and V8 protease. Shown are the percentages of identical amino acids calculated using paired alignments of the proteins.
Comparison of the SplA, SplB, and SplF N-terminal sequences with the deduced amino acid sequences of the splA, splB, andsplF gene products revealed matches starting 35 or 36 residues downstream of the putative N-terminal methionines, respectively. The product of the splC gene was also detected in IEF gels, purified (Fig. 1A, lane 5), and shown to have an N-terminal sequence (EKNVTQVKDT) that was identical to the deduced amino acid sequence 37 residues downstream of the N-terminal methionine. These data indicate that at least four of the proteins encoded by this operon contain 35-or 36-residue-long signal peptides (Table 2) consistent with secretion in a Sec-dependent manner. The predicted mature protein products ranged in size from 21.9 to 22.4 kDa and, with the exception of the third gene product (SplC), are predicted to be basic proteins having isoelectric points of approximately 9.0 (Table 2). The predicted neutral isoelectric point of the third gene product is consistent with its absence in our initial purified protein preparation of SplA, SplB, and SplF (Fig. 1A, lane 4).
Table 2.
Table 2. Characteristics of mature Spl proteins
ProteinNo. of amino acidsMolecular mass (kDa)Deduced pINo. of amino acids in signal sequence
SplA20021.98.635
SplB20422.49.136
SplC20322.46.436
SplD20322.08.936
SplE20222.09.236
SplF20321.98.936
To determine whether the spl operon encodes protease activity, we tested purified preparations of SplB and SplC for the ability to degrade casein. As shown in Fig. 1B, a zymographic analysis using casein as the substrate revealed clear zones of hydrolysis corresponding to the purified proteins, indicating that SplB and SplC exhibit protease activity. Although the other Spl proteins were not tested, it is likely that they also exhibit protease activity based on the high degree of sequence conservation exhibited by all of thespl gene products (including the catalytic triads).

Northern analysis.

Since the expression of most staphylococcal exoprotein genes is activated during the transition into stationary phase and is dependent on the virulence factor regulator Agr, we examined the expression of the spl operon during various stages of growth. RNA was isolated from S. aureus RN6390 cultures in 2-h increments beginning in exponential phase (4 h) and extending to stationary phase (12 h). RNA was analyzed by dot blot hybridization using an splB-specific DNA probe. As shown in Fig. 5, maximal expression ofsplB-specific transcripts was detected at the 8-h time point, which corresponded to early stationary phase (unpublished results).
Fig. 5.
Fig. 5. Temporal regulation of the spl operon. Dot blot analysis of total cellular RNA isolated from RN6390 at 4, 6, 8, 10, and 12 h postinoculation and probed with ansplB-specific probe. The 8-h time point corresponds to the transition into stationary phase.
The six spl genes span a total of 4,916 nucleotides and are separated by 57- to 157-bp spacer regions. Immediately downstream ofsplF is an inverted repeat sequence that is a potential factor-independent transcription terminator. The absence of inverted repeat sequences downstream of any other spl gene suggests that the six spl genes are cotranscribed, with transcription terminating downstream of splF. As determined by Northern blot analysis (Fig. 6), several transcripts in RN6390 hybridized to splB-, splC-, and splF-specific probes, while only the largest (5.5 kb) of these hybridized to the splA-specific probe. The observation that the splF-specific probe hybridized to all of the transcripts suggests that all of these transcripts have the same 3′ terminus. Assuming that these transcripts terminate just downstream of the splF gene (near the putative transcription terminator), the start of transcription for the 5.5-kb transcript is estimated to be located approximately 400 bp upstream of the splA start codon. Experiments using any of the spl-specific sequences to probe RNA from KB601 (a strain that contained an integrated plasmid in the splB gene) did not detect hybridization to the 5.5-kb RNA. Instead, a 2.3-kb transcript, possibly representing a truncated version resulting from the plasmid integration in splB, was detected only with the splA- or splB-specific probes. Since any promoters downstream of splB would likely be unaffected by the integrated plasmid, these results suggest that the largest transcript spans the entire operon and that the smaller transcripts are nonrandom degradation products.
Fig. 6.
Fig. 6. Northern blot analysis of the spl operon. DNA probes specific for splA, splB, splC, and splF were hybridized with RNAs isolated from RN6390 (lanes 1) and KB601 (lanes 2). Transcript sizes were determined based on the migration of a 0.24 to 9.5-kb RNA ladder (Gibco-BRL).
To examine the roles of Agr and Sar in spl expression, a Northern blot analysis was performed on RNA isolated from RN6911 (agr), ALC135 (agr sar), and ALC136 (sar) when the spl operon was maximally expressed in the parental strain (during the transition from exponential to stationary phase). As shown in Fig. 7, there was no hybridization to RN6911 (agr) and ALC136 (agr sar) RNA using an splB-specific probe (otherspl-specific probes gave similar [unpublished] results), demonstrating regulation by Agr. Hybridization of each probe to ALC135 (sar) RNA occurred at levels equivalent to hybridization to RN6390.
Fig. 7.
Fig. 7. Transcriptional regulation of the spl operon. A DNA probe specific for splB was hybridized with RNAs isolated from RN6390 (lane 1), KB600 (lane 2), ALC136 (lane 3), ALC135 (lane 4), and RN6911 (lane 5). Transcript sizes were determined based on the migration of a 0.24 to 9.5-kb RNA ladder (Gibco-BRL).

PCR analysis of clinical isolates.

To examine if thespl genes are present in other strains, 11 randomly selectedS. aureus isolates (Table 1) were analyzed by PCR amplification using splA- and splD-specific primers. PCR amplification of DNA from these isolates usingspl operon-specific primers successfully amplified a 2.8-kb DNA fragment (presumably containing splA, splB,splC, and part of splD) in seven (64%) of the isolates tested (data not shown). With the exception of the Brittingham strain, the results of the PCR survey were confirmed by Southern blot analysis. Although the Brittingham strain produced no DNA fragment in PCR amplification using primers specific to the spl operon, Southern blot analysis revealed the presence of sequences that hybridized to splC- and splD/F-specific probes, but not to probes specific for splA and splB(data not shown).

Virulence studies.

The role of virulence factors during the course of infection is most easily determined by generating mutant strains and then assessing their ability to cause disease in an animal model of infection. Accordingly, the entire spl operon was replaced in RN6390 with an Emr determinant (see Materials and Methods), resulting in strain KB600. SDS-PAGE analysis of the exoproteins produced by this strain confirmed that it failed to produce the Spl proteins (unpublished data). Furthermore, transformation of KB600 with the spl operon expression plasmid pSR7 resulted in restoration of spl expression. To assess the effects of the spl operon on staphylococcal pathogenesis, three dosages (107, 108, and 109 CFU) of RN6390, KB600, and KB600(pSR7) were intraperitoneally injected into 29-day-old rats. Examination of these animals revealed no differences in the 50% lethal dose or the time required to cause death. Furthermore, no differences in the lesions produced by these strains were observed. Thus, the spl operon plays no obvious role in virulence as determined by this animal infection model.

DISCUSSION

The results presented here demonstrate the presence of a novelS. aureus six-gene operon (designated spl) that encodes protease activity. Members of the serine protease family, including V8 protease and the ETs, contain a well-conserved active site, known as a catalytic triad (4, 10, 11). This motif is characterized by the presence of a highly reactive serine residue within hydrogen-bonding distance of an imidazole ring nitrogen of histidine and a transition state-stabilizing aspartate residue (6, 14). Similarly, the Spl proteins contain the catalytic triad and exhibit significant sequence similarity to V8 protease and the ETs. Although only the SplB and SplC proteins were purified to homogeneity and shown by zymographic analysis to exhibit protease activity (Fig. 1B), we speculate that all of the Spl proteins are proteases.
The splC gene product was identified previously using antisera from S. aureus endocarditis patients to screen an expression library for genes that are expressed in vivo (28). Analysis of the deduced amino acid sequence of this antigen (designated ORF2) also demonstrated significant sequence similarity to the serine proteases V8 and the ETs. Furthermore, the presence of a catalytic triad within ORF2 was also noted by these authors, leading them to speculate that ORF2 is a protease. The fact that patients' sera reacted with ORF2 indicates that this protein is expressed in S. aureus endocarditis and thus may be an important virulence factor during the course of this infection. In an initial assessment of virulence, a murine intraperitoneal injection model was used in this study to compare the effects of S. aureus RN6390 and its isogenic spl mutant. Although we were unable to observe effects on virulence in this model, more extensive studies using animals more sensitive to S. aureusare ongoing.
It has been presumed that various staphylococcal proteases might function as virulence factors through a variety of mechanisms, including inactivation of antimicrobial peptides, cleavage of human immunoglobin molecules, and allowing dissemination by tissue destruction (15, 31). V8 protease can cleave and inactivate the heavy chains of all human immunoglobin classes in vitro (1, 23) and modify the fibronectin-binding phenotype ofS. aureus (21). The degradation of adhesins in the postexponential growth phase could allow the bacteria to spread from initial sites of infection (21). Metalloprotease is required for cleavage of V8 protease from an inactive precursor to a mature protease (12), and the ability of metalloprotease to activate prothrombin in human plasma suggests a role in the disseminated intravascular coagulation that sometimes occurs after systemic infection (34). ETA and ETB, the etiological agents of staphylococcal scalded-skin syndrome, exhibit 25 to 30% similarity to V8 protease. Like V8 protease, the ETs belong to the serine protease family (10) but are dissimilar in their high substrate specificity (25). Epidermolytic activity is lost in mutant toxins with alterations in the catalytic triad region, suggesting that proteolytic activity is essential (27). Recently, Rago et al. (25) revealed that β-melanocyte-stimulating hormone is a substrate of ETA and that both ETA and ETB cleave α-melanocyte-stimulating hormone. These revelations provide important new insight into the mechanisms of the skin desquamation that is associated with these toxins. Whether thespl gene products have a specific substrate like the ETs or whether they are nonspecific proteases involved in tissue destruction is currently under investigation in our laboratories.

ACKNOWLEDGMENTS

We thank the Staphylococcus aureus Genome Sequencing Project and B. A. Roe, Yudong Qian, A. Dorman, F. Z. Najar, S. Clifton, and J. Iandolo, with funding from the NIH and the Merck Genome Research Institute, for providing the spl operon sequence data.
This study was supported by NIH grant R29-AI38901 (K.W.B.), NSF-Idaho EPSCoR grant EPS-9720634 (K.W.B.), NRICGP USDA grant 9402399 (G.A.B.), Public Health Service grant AI28401 (G.A.B.), and the United Dairymen of Idaho (G.A.B.). We acknowledge the support of the Idaho Agriculture Experiment Station (grant 528).

REFERENCES

1.
Arvidson A. Extracellular proteases Gram-positive pathogens. Fischetti V. A., Novick R. P., Ferretti J. J., Portnoy D. A., and Rood J. I. 2000 379 -385 American Society for Microbiology Washington, D.C.
2.
Arvidson S., Holme T., and Lindholm B. Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease.Biochim. Biophys. Acta3021973135-148
3.
Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., and Struhl K. Current protocols in molecular biology. 1991 John Wiley & Sons New York, N.Y
4.
Bailey C. J., Lockhart B. P., Redpath M. B., and Smith T. P. The epidermolytic (exfoliative) toxins of Staphylococcus aureus.Med. Microbiol. Immunol.184199553-61
5.
Bayles K. W., Brunskill E. W., Iandolo J. J., Hruska L. L., Huang S., Pattee P. A., Smiley B. K., and Yasbin R. E. A genetic and molecular characterization of the recA gene from Staphylococcus aureus.Gene147199413-20
6.
Blow D. Enzymology. More of the catalytic triad.Nature3431990694-695
7.
Chan P. F. and Foster S. J. Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus.J. Bacteriol.18019986232-6241
8.
Cheung A. L., Eberhardt K. J., Chung E., Yeaman M. R., Sullam P. M., Ramos M., and Bayer A. S. Diminished virulence of a sar−/agr− mutant of Staphylococcus aureus in the rabbit model of endocarditis.J. Clin. Investig.9419941815-1822
9.
Cheung A. L. and Projan S. J. Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr.J. Bacteriol.17619944168-4172
10.
Dancer S. J., Garratt R., Saldanha J., Jhoti H., and Evans R. The epidermolytic toxins are serine proteases.FEBS Lett.2681990129-132
11.
Drapeau G. R. Cleavage at glutamic acid with staphylococcal protease.Methods Enzymol.471977189-191
12.
Drapeau G. R. Role of metalloprotease in activation of the precursor of staphylococcal protease.J. Bacteriol.1361978607-613
13.
Dyer D. W. and Iandolo J. J. Rapid isolation of DNA from Staphylococcus aureus.Appl. Environ. Microbiol.461983283-285
14.
Frey P. A., Whitt S. A., and Tobin J. B. A low-barrier hydrogen bond in the catalytic triad of serine proteases.Science26419941927-1930
15.
Goguen J. D., Hoe N. P., and Subrahmanyam Y. V. Proteases and bacterial virulence: a view from the trenches.Infect. Agents Dis.4199547-54
16.
Guerout-Fleury A. M., Shazand K., Frandsen N., and Stragier P. Antibiotic-resistance cassettes for Bacillus subtilis.Gene1671995335-336
17.
Inoue H., Nojima H., and Okayama H. High efficiency transformation of Escherichia coli with plasmids.Gene96199023-28
18.
Kornblum J., Kreiswirth B. N., Projan S. J., Ross H., and Novick R. P. Agr: a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus Molecular biology of the staphylococci. Novick R. P. 1990 373 -402 VCH Publishers, Inc. New York, N.Y
19.
Kraemer G. R. and Iandolo J. J. High-frequency transformation of Staphylococcus aureus by electroporation.Curr. Microbiol.211990373-376
20.
Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.J. Biol. Chem.262198710035-10038
21.
McGavin M. J., Zahradka C., Rice K., and Scott J. E. Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease.Infect. Immun.6519972621-2628
22.
Newbould F. H. Antibiotic treatment of experimental Staphylococcus aureus infections of the bovine mammary gland.Can. J. Comp. Med. Vet. Sci.381974411-416
23.
Novick R. P. The staphylococcus as a molecular genetic system Molecular biology of the staphylococci. Novick R. P. 1990 1 -37 VCH Publishers New York, N.Y
24.
Novick R. P., Ross H. F., Projan S. J., Kornblum J., Kreiswirth B., and Moghazeh S. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.EMBO J.1219933967-3975
25.
Rago J. V., Vath G. M., Tripp T. J., Bohach G. A., Ohlendorf D. H., and Schlievert P. M. Staphylococcal exfoliative toxins cleave α- and β- melanocyte-stimulating hormones.Infect. Immun.6820002366-2368
26.
Recsei P., Kreiswirth B., O'Reilly M., Schlievert P., Gruss A., and Novick R. P. Regulation of exoprotein gene expression in Staphylococcus aureus by agr.Mol. Gen. Genet.202198558-61
27.
Redpath M. B., Foster T. J., and Bailey C. J. The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus.FEMS Microbiol. Lett.651991151-155
28.
Rieneck K., Renneberg J., Diamant M., Gutschik E., and Bendtzen K. Molecular cloning and expression of a novel Staphylococcus aureus antigen.Biochim. Biophys. Acta13501997128-132
29.
Sambrook J., Fritsch E. F., and Maniatis T. Molecular cloning: a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, N.Y
30.
Sau S., Sun J., and Lee C. Y. Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus.J. Bacteriol.17919971614-1621
31.
Selsted M. E., Tang Y. Q., Morris W. L., McGuire P. A., Novotny M. J., Smith W., Henschen A. H., and Cullor J. S. Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.J. Biol. Chem.271199616430
32.
Shafer M. W. and Iandolo J. J. Genetics of staphylococcal enterotoxin B in methicillin-resistant isolates of Staphylococcus aureus.Infect. Immun.251979902-911
33.
Smith T. H., Fox L. K., and Middleton J. R. Outbreak of mastitis caused by one strain of Staphylococcus aureus in a closed dairy herd.J. Am. Vet. Med. Assoc.2121998553-556
34.
Wegrzynowicz Z., Heczko P. B., Drapeau G. R., Jeljaszewicz J., and Pulverer G. Prothrombin activation by a metalloprotease from Staphylococcus aureus.J. Clin. Microbiol.121980138-139

Information & Contributors

Information

Published In

cover image Infection and Immunity
Infection and Immunity
Volume 69Number 31 March 2001
Pages: 1521 - 1527
Editor: E. I. Tuomanen
PubMed: 11179322

History

Received: 11 October 2000
Returned for modification: 1 December 2000
Accepted: 18 December 2000
Published online: 1 March 2001

Permissions

Request permissions for this article.

Contributors

Authors

Samantha B. Reed
Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844-3052,1 and
Carla A. Wesson
Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844-3052,1 and
Linda E. Liou
Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844-3052,1 and
William R. Trumble
Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844-3052,1 and
Patrick M. Schlievert
Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 554552
Gregory A. Bohach
Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844-3052,1 and
Kenneth W. Bayles
Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844-3052,1 and

Editor

E. I. Tuomanen

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy